Twist Bioscience Corp's stock is experiencing a notable uptick as investor sentiment remains positive.
Twist Bioscience Corp (NASDAQ:TWST) is rising today, showing a gain of 3.47% in its stock price. This upward movement comes amidst growing interest in the company's innovative approaches in biotechnology and collaborations that enhance its market position.
Advertisement
Twist Bioscience Corp
TWST.US
TWST.US
Twist Bioscience Corp
WealthAwesomeMarket cap
$12.34B
52W high
$190.76
52W low
$23.30
1W change
+13.08%
Beta
2.22
Analyst Price Targets
Based on 12 analysts covering TWST · as of Sep 21, 2026
Wall Street analysts forecast TWST stock price to fall 41.1% over the next 12 months.
Consensus
Buy4.17 / 5.00
Avg. Target
C$109.58
-41.1% Upside
Previously C$106.25 on Sep 17, 2026
Current Price
C$186.13
Last close
Analyst Breakdown (12 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TWST's historical volatility
30-Day Vol
97.2%
Annualized
90-Day Vol
86.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$222.52
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$197.55 | C$141.28 – C$276.22 |
| 60 trading days | C$209.66 | C$130.50 – C$336.83 |
| 90 trading days | C$222.52 | C$124.51 – C$397.69 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are encouraged by Twist Bioscience's strategic partnerships and advancements in AI-driven drug discovery, indicating potential for future growth.
Market Cap Reaches $12.34 Billion
With a market cap of approximately $12.34 billion, Twist Bioscience is establishing itself as a significant player in the biotechnology sector, attracting investor interest.
Bull case
Twist Bioscience's partnerships with major pharmaceutical companies, especially in AI drug discovery, put it in a strong position to gain market share in the biotech sector. This could lead to increased revenues as the company continues to innovate and expand its reach.
Bear case
Despite its growth potential, Twist Bioscience faces challenges. The biotech space is competitive, and the company needs to show consistent profitability to keep investors interested. These factors might make some investors hesitant.
Advertisement
Strong Partnerships Fuel Growth
Twist Bioscience has recently expanded its partnerships, particularly in AI-driven drug discovery. Collaborations with major pharmaceutical firms are expected to enhance its research capabilities and market reach, making it a more attractive investment option.
Market Performance and Investor Sentiment
With a market cap of $12.34 billion, Twist Bioscience's stock performance is catching the eye of investors. The recent rise in stock price reflects a growing confidence in the company's strategic direction and potential for future profitability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
